News
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
According to reports, a cause for concern is that 51 of the cases involve infants under one year of age, while 553 are among ...
The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths. About 80,000 Ixchiq doses have ...
US Health Officials Advise Older Travelers Not to Get a Chikungunya Vaccine NEW YORK ... problems — who became ill with heart or brain symptoms less than a week after vaccination.
TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine ... serious heart or brain symptoms within a week of ...
A vaccine designed to protect against chikungunya, a mosquito-borne illness, has been temporarily paused for individuals aged 60 and older.
TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...
Chikungunya, spread by the bites of infected ... with other medical problems — who became ill with heart or brain symptoms less than a week after vaccination. More than 10 other similar cases ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results